多态学签名揭示了CRC连续性的网络监管机制
Juan Carlos Higareda-Almaraz1, Francesco Mattia Mancuso1, Pol Canal-Noguer1
1Universal Diagnostics S.A., 41013 Seville, Spain.
International journal of molecular sciences
|August 14, 2025
概括
研究人员确定了DNA甲基化特征,以区分早期结直肠癌 (CRC) 阶段. 这种特征可以准确地区分低度和高度的发育不良,并有助于对CRC亚型进行分类,从而有可能改善早期检测.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 癌症生物学 癌症生物学
- 基因组学就是基因组学.
背景情况:
- 散发性结肠直肠癌 (CRC) 是一个主要的全球健康问题,从正常组织通过低度形 (LGD) 进展到高度形 (HGD),先于侵入性癌症.
- 早期的表观遗传事件驱动过渡从LGD到HGD在CRC仍然不太了解.
研究的目的:
- 确定结直肠癌进展的早期表观遗传驱动因素.
- 开发DNA甲基化特征,用于分层发育不良症的严重程度和分类CRC亚型.
主要方法:
- 利用EM-seq对LGD和HGD腺瘤的DNA甲基化进行分析.
- 采用两个独立的生物信息管道来确定626个地区的共识差异甲基化签名 (DMS).
- 在组织和血衍生的无细胞DNA (cfDNA) 中验证了DMS,并将其应用于癌症基因组图谱 (TCGA) CRC数据集.
主要成果:
- 在组织和cfDNA中有效区分LGD和HGD的626区域DMS.
- 功能注释揭示了DMS在与转录因子活性和细胞信号相关的调控元素中的丰富.
- 该DMS将TCGACRC样品分为三个高甲基化瘤亚型和一个正常,其中最多甲基化亚型的生存率较低,突变负担较高.
结论:
- 开发的DMS捕捉了功能相关的,在CRC进展中的先行表观遗传变化.
- 这种特征使得难形成症严重程度和CRC瘤亚型的稳健分层成为可能.
- DMS显示了增强临床前CRC检测和分子分类的前景.
关键词:
晚期腺瘤是晚期的腺瘤.结肠直肠癌是什么意思早期检测 早期检测高度的发育不良症.低度的发育不良症是一种低度的发育不良症.甲基化疗法 甲基化疗法多种多种多种多种多种多种多种多种多种多种.监管网络监管网络监管网络监管网络监管更多相关视频
07:47Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies
Published on: September 15, 2023
1.6K
10:33Molecular Profiling of the Invasive Tumor Microenvironment in a 3-Dimensional Model of Colorectal Cancer Cells and Ex vivo Fibroblasts
Published on: April 29, 2014
11.2K
相关概念视频
Interactions Between Signaling Pathways
6.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
PI3K/mTOR/AKT Signaling Pathway
4.0K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
4.0K
Regulation of Expression at Multiple Steps
1.0K
The gene expression in cells is regulated at different stages: (i) transcription, (ii) RNA processing, (iii) RNA localization, and (iv) translation. Transcriptional regulation is mediated by regulatory proteins such as transcription factors, activators, or repressors—these control gene expression by initiating or inhibiting the transcription of genes. Once a precursor or pre-mRNA is produced, it undergoes post-transcriptional modification, including 5' capping, splicing, and the...
1.0K
